Klotho Endows Hepatoma Cells with Resistance to Anoikis via VEGFR2/PAK1 Activation in Hepatocellular Carcinoma

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Chen, Lin ^a   Liu, Haiou ^a   Liu, Jing ^b   Zhu, Yu ^a   Xu, Le ^a   He, Hongyong ^a   Zhang, Heng ^a   Wang, Shanshan ^a   Wu, Qian ^a   Liu, Weisi ^a   Liu, Yidong ^a   Pan, Deng ^a   Ren, Shifang ^a   Xu, Jiejie ^a   Gu, Jianxin ^a  

^a FUDAN UNIVERSITY   (China)

^b NANTONG MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AXITINIB; KLOTHO PROTEIN; P21 ACTIVATED KINASE 1; SHORT HAIRPIN RNA; VASCULOTROPIN RECEPTOR 2;

ANOIKIS; ARTICLE; CANCER INVASION; CANCER RESISTANCE; CANCER SURVIVAL; CELL ANCHORAGE; CELL GROWTH; CELL MIGRATION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVATION; ENZYME INHIBITION; FEMALE; GENE FUNCTION; GENE OVEREXPRESSION; HEPATOMA CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING; KLOTHO GENE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROTEIN FUNCTION; SURVIVAL RATE; UPREGULATION;

ANOIKIS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; ENZYME ACTIVATION; FEMALE; GLUCURONIDASE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; P21-ACTIVATED KINASES; RNA INTERFERENCE; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84874868426     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058413     Document Type: Article

References (39)

1. El-Serag HB, Rudolph KL, (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132: 2557-2576.
2. Thomas MB, Jaffe D, Choti MM, Belghiti J, Curley S, et al. (2010) Hepatocellular carcinoma: consensus recommendations of the National Cancer Institute Clinical Trials Planning Meeting. J Clin Oncol 28: 3994-4005.
3. Aravalli RN, Steer CJ, Cressman EN, (2008) Molecular mechanisms of hepatocellular carcinoma. Hepatology 48: 2047-2063.
4. Eccles SA, Welch DR, (2007) Metastasis: recent discoveries and novel treatment strategies. Lancet 369: 1742-1757.
5. Gilmore AP, (2005) Anoikis. Cell Death Differ 12Suppl 2: 1473-1477.
6. Xu J, Liu H, Chen L, Wang S, Zhou L, et al. (2012) Hepatitis B virus X protein confers resistance of hepatoma cells to anoikis by up-regulating and activating p21-activated kinase 1. Gastroenterology 143: 199-212 e194.
7. Chen S, Yin X, Zhu X, Yan J, Ji S, et al. (2003) The C-terminal kinase domain of the p34cdc2-related PITSLRE protein kinase (p110C) associates with p21-activated kinase 1 and inhibits its activity during anoikis. J Biol Chem 278: 20029-20036.
8. Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, et al. (1997) Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390: 45-51.
9. Nagai T, Yamada K, Kim HC, Kim YS, Noda Y, et al. (2003) Cognition impairment in the genetic model of aging klotho gene mutant mice: a role of oxidative stress. FASEB J 17: 50-52.
10. Nagai R, Saito Y, Ohyama Y, Aizawa H, Suga T, et al. (2000) Endothelial dysfunction in the klotho mouse and downregulation of klotho gene expression in various animal models of vascular and metabolic diseases. Cell Mol Life Sci 57: 738-746.
11. Saito Y, Yamagishi T, Nakamura T, Ohyama Y, Aizawa H, et al. (1998) Klotho protein protects against endothelial dysfunction. Biochem Biophys Res Commun 248: 324-329.
12. Arking DE, Krebsova A, Macek M Sr, Macek M Jr, Arking A, et al. (2002) Association of human aging with a functional variant of klotho. Proc Natl Acad Sci U S A 99: 856-861.
13. Liu F, Wu S, Ren H, Gu J, (2011) Klotho suppresses RIG-I-mediated senescence-associated inflammation. Nat Cell Biol 13: 254-262.
14. Cheng C, Kong X, Wang H, Gan H, Hao Y, et al. (2009) Trihydrophobin 1 Interacts with PAK1 and Regulates ERK/MAPK Activation and Cell Migration. J Biol Chem 284: 8786-8796.
15. Xu J, Yun X, Jiang J, Wei Y, Wu Y, et al. (2010) Hepatitis B virus X protein blunts senescence-like growth arrest of human hepatocellular carcinoma by reducing Notch1 cleavage. Hepatology 52: 142-154.
16. Liu H, Xu J, Zhou L, Yun X, Chen L, et al. (2011) Hepatitis B virus large surface antigen promotes liver carcinogenesis by activating the Src/PI3K/Akt pathway. Cancer Res 71: 7547-7557.
17. He H, Chen W, Wang X, Wang C, Liu F, et al. (2012) Snail is an independent prognostic predictor for progression and patient survival of gastric cancer. Cancer Sci.
18. Xu L, Zhu Y, Xu J, Wu K, Li J, et al. (2012) Notch1 activation promotes renal cell carcinoma growth via PI3K/Akt signaling. Cancer Sci.
19. Liu H, Xu L, He H, Zhu Y, Liu J, et al. (2012) Hepatitis B virus X protein promotes hepatoma cell invasion and metastasis via stabilizing Snail protein. Cancer Sci.
20. Zhang W, Xu W, Xiong S, (2010) Blockade of Notch1 signaling alleviates murine lupus via blunting macrophage activation and M2b polarization. J Immunol 184: 6465-6478.
21. Zhang W, Xu W, Xiong S, (2011) Macrophage differentiation and polarization via phosphatidylinositol 3-kinase/Akt-ERK signaling pathway conferred by serum amyloid P component. J Immunol 187: 1764-1777.
22. Nagaprashantha LD, Vatsyayan R, Lelsani PC, Awasthi S, Singhal SS, (2011) The sensors and regulators of cell-matrix surveillance in anoikis resistance of tumors. Int J Cancer 128: 743-752.
23. Kusaba T, Okigaki M, Matui A, Murakami M, Ishikawa K, et al. (2010) Klotho is associated with VEGF receptor-2 and the transient receptor potential canonical-1 Ca2+ channel to maintain endothelial integrity. Proc Natl Acad Sci U S A 107: 19308-19313.
24. Woolfolk EA, Eguchi S, Ohtsu H, Nakashima H, Ueno H, et al. (2005) Angiotensin II-induced activation of p21-activated kinase 1 requires Ca2+ and protein kinase C{delta} in vascular smooth muscle cells. Am J Physiol Cell Physiol 289: C1286-1294.
25. Kurosu H, Ogawa Y, Miyoshi M, Yamamoto M, Nandi A, et al. (2006) Regulation of fibroblast growth factor-23 signaling by klotho. J Biol Chem 281: 6120-6123.
26. Urakawa I, Yamazaki Y, Shimada T, Iijima K, Hasegawa H, et al. (2006) Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 444: 770-774.
27. Chang Q, Hoefs S, van der Kemp AW, Topala CN, Bindels RJ, et al. (2005) The beta-glucuronidase klotho hydrolyzes and activates the TRPV5 channel. Science 310: 490-493.
28. Yamamoto M, Clark JD, Pastor JV, Gurnani P, Nandi A, et al. (2005) Regulation of oxidative stress by the anti-aging hormone klotho. J Biol Chem 280: 38029-38034.
29. Kurosu H, Yamamoto M, Clark JD, Pastor JV, Nandi A, et al. (2005) Suppression of aging in mice by the hormone Klotho. Science 309: 1829-1833.
30. Mitobe M, Yoshida T, Sugiura H, Shirota S, Tsuchiya K, et al. (2005) Oxidative stress decreases klotho expression in a mouse kidney cell line. Nephron Exp Nephrol 101: e67-74.
31. Ikushima M, Rakugi H, Ishikawa K, Maekawa Y, Yamamoto K, et al. (2006) Anti-apoptotic and anti-senescence effects of Klotho on vascular endothelial cells. Biochem Biophys Res Commun 339: 827-832.
32. Liu H, Fergusson MM, Castilho RM, Liu J, Cao L, et al. (2007) Augmented Wnt signaling in a mammalian model of accelerated aging. Science 317: 803-806.
33. Nussbaum T, Samarin J, Ehemann V, Bissinger M, Ryschich E, et al. (2008) Autocrine insulin-like growth factor-II stimulation of tumor cell migration is a progression step in human hepatocarcinogenesis. Hepatology 48: 146-156.
34. Fukino K, Suzuki T, Saito Y, Shindo T, Amaki T, et al. (2002) Regulation of angiogenesis by the aging suppressor gene klotho. Biochem Biophys Res Commun 293: 332-337.
35. Wolf I, Levanon-Cohen S, Bose S, Ligumsky H, Sredni B, et al. (2008) Klotho: a tumor suppressor and a modulator of the IGF-1 and FGF pathways in human breast cancer. Oncogene 27: 7094-7105.
36. Doi S, Zou Y, Togao O, Pastor JV, John GB, et al. (2011) Klotho inhibits transforming growth factor-beta1 (TGF-beta1) signaling and suppresses renal fibrosis and cancer metastasis in mice. J Biol Chem 286: 8655-8665.
37. Chen B, Wang X, Zhao W, Wu J, (2010) Klotho inhibits growth and promotes apoptosis in human lung cancer cell line A549. J Exp Clin Cancer Res 29: 99.
38. Lu L, Katsaros D, Wiley A, de la Longrais IA, Puopolo M, et al. (2008) Klotho expression in epithelial ovarian cancer and its association with insulin-like growth factors and disease progression. Cancer Invest 26: 185-192.
39. Villanueva A, Llovet JM, (2011) Targeted therapies for hepatocellular carcinoma. Gastroenterology 140: 1410-1426.